Is Trientine covered by medical insurance?

Trientine is a drug used to treat Wilson's disease, a genetic disorder that causes excessive accumulation of copper in the body, causing damage to the liver, brain and other organs. Trientine acts on the copper metabolism mechanism in the body to help eliminate excess copper ions and reduce its concentration in tissues, thereby alleviating symptoms and preventing complications. Trientine is a diamine compound whose main function is to form a complex with copper ions so that it can be dissolved and excreted through urine.

In the international market, trientine is considered an effective treatment option for patients with Wilson's disease, especially those who experience adverse reactions or are intolerant to other drugs such as penicillamine. Because trientine is well tolerated and has relatively few side effects, it is favored in clinical applications.

Although the use of trientine is relatively mature abroad, the situation in the Chinese market is relatively complicated. Currently, the original drug of trientine is on the market through specific channels in some areas of Hainan. However, its purchase channels are limited and its price is also restricted, which makes patients face certain obstacles in accessing the drug. In addition, there is no clear information on whether trientine is included in medical insurance, which means that many patients may need to pay for it out of pocket, increasing their financial burden.

Although the number of patients with Wilson's disease in China is not huge, timely and effective treatment is crucial due to the particularity of the disease and its impact on quality of life. Therefore, issues of accessibility and price of trientine as a potential treatment option are particularly important. For patients, whether they can successfully obtain trientine and the reasonableness of its cost are directly related to their treatment effects and quality of life.

Reference materials:https://www.ncbi.nlm.nih.gov/books/NBK548119/